Search results
Results from the Tech24 Deals Content Network
NGM Biopharmaceuticals (NGM) delivered earnings and revenue surprises of 0% and 6.26%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
The mean of analysts' price targets for NGM Biopharmaceuticals (NGM) points to a 461.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ...
Shareholders in NGM Biopharmaceuticals, Inc. ( NASDAQ:NGM ) may be thrilled to learn that the analysts have just...
Tom Williams via Getty Images. Nineteen members of Congress are pushing Mark Zuckerberg to explain why Meta has allowed ads for cocaine, ecstasy and other drugs to be shown on Facebook and ...
List of largest biomedical companies by revenue. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$ 10 billion, ranked by their revenue in the respective financial year. It does not include biotechnology companies that ...
NGM Biopharmaceuticals (NGM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Nordic Growth Market (NGM Exchange) is a regulated exchange that delivers trading, exchange technology and public company services. Established in 1984, the exchange operates in Sweden, Finland, Denmark, and Norway. Since 2008, Nordic Growth Market is a fully owned subsidiary of Börse Stuttgart, one of the leading exchanges in Europe.